XuanZhu Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:XuanZhu Pharma Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011864
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd is a healthcare company that research, develops, manufactures and sales drugs. The company’s products include anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic drug imigliptin hydrochloride and anti-hypertensive drug tylerdipine hydrochloride. Its technology platforms include drug analysis lab, preparation research lab, lab for crystal form study and salt selection, BSL-2 lab, lab for pharmacokinetics and drug metabolism among others. The company provides products in the therapeutic areas including cardiology, oncology, and others. XuanZhu is headquartered in Jinan, China.

XuanZhu Pharma Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 10
Covance Enters into Co-Development Agreement with Sihuan Pharma 11
Acquisition 12
Sihuan Pharma Acquires 40% Stake in XuanZhu Pharma 12
XuanZhu Pharma Co Ltd – Key Competitors 13
XuanZhu Pharma Co Ltd – Key Employees 14
XuanZhu Pharma Co Ltd – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
08/04/2016: CFDA Granted Approval of Phase II/III Clinical Trials for Imigliptin Hydrochloride 16
07/28/2016: Sihuan Pharmaceutical Secures CFDA approval for Imigliptin Dihydrochloride Phase II/III Clinical Trials 17
Clinical Trials 18
Dec 14, 2016: CFDA Granted Approval forPhase I/II/III Clinical Trials of Sihuan Pharmaceutical’s Internally Developed Innovative Patented New Drug – Fadanafil 18
Aug 26, 2016: CFDA Granted Approval of Phase I-III Clinical Trials for Sirotinib (XZP – 5491) 19
Mar 21, 2016: CFDA Granted Approval for Clinical Trials of Internally-developed Category 1.1 Innovative Anti-diabetic Drug – Janagliflozin 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
XuanZhu Pharma Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
XuanZhu Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 10
Covance Enters into Co-Development Agreement with Sihuan Pharma 11
Sihuan Pharma Acquires 40% Stake in XuanZhu Pharma 12
XuanZhu Pharma Co Ltd, Key Competitors 13
XuanZhu Pharma Co Ltd, Key Employees 14

★海外企業調査レポート[XuanZhu Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nohmi Bosai Ltd:企業の戦略・SWOT・財務情報
    Nohmi Bosai Ltd - Strategy, SWOT and Corporate Finance Report Summary Nohmi Bosai Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Synedgen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Synedgen Inc (Synedgen) is a biotechnology company that focuses on the discovery and development of polysaccharide-based drugs. The company’s pipeline products include SYGN 113; SYGN 115; SYGN 146; SYGN 303; SYGN 313 and SYGN 399 among others. Synedgen develops products for the treatment of …
  • Westar Energy Inc (WR)-エネルギー分野:企業M&A・提携分析
    Summary Westar Energy, Inc. (Westar Energy) is a vertically integrated energy utility that generates, transmits and distributes electricity. The company owns and operates a generation portfolio of coal-fired, nuclear, natural gas-based, renewable and diesel-based power plants. It also procures elect …
  • NovoCure Ltd (NVCR):企業の製品パイプライン分析
    Summary NovoCure Ltd (NovoCure) develops and commercializes novel delivery systems for the treatment of cancers of brain, abdomen, and torso. Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division solid tumor can …
  • Shanghai Kehua Bio-engineering Co Ltd (002022):企業の財務・戦略的SWOT分析
    Shanghai Kehua Bio-engineering Co Ltd (002022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Theravance Biopharma Inc (TBPH):企業の財務・戦略的SWOT分析
    Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Linde AG (LIN):企業の財務・戦略的SWOT分析
    Linde AG (LIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Voith GmbH & Co KGaA:企業の戦略的SWOT分析
    Voith GmbH & Co KGaA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Apache Corp (APA):石油・ガス:M&Aディール及び事業提携情報
    Summary Apache Corp (Apache) is an independent upstream energy company, which carries out exploration, development and production of natural gas, crude oil and natural gas liquids (NGLs). It has onshore and offshore asset base consisting of operations in the Permian Basin, the Anadarko basin in west …
  • Medpace Inc (MEDP):企業の財務・戦略的SWOT分析
    Summary Medpace Inc (Medpace), a subsidiary of Medpace Holdings Inc is a contract research organization that develops research based drug and medical device. The organization provides services such as medical affairs, regulatory affairs and medical writing, clinical monitoring, clinical trial manage …
  • The Bank Of East Asia, Limited
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ivy Cosmetics Corporation:企業の戦略・SWOT・財務分析
    Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report Summary Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nokia Corp (NOKIA):企業の財務・戦略的SWOT分析
    Nokia Corp (NOKIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Pt Bumi Resources Tbk:企業の戦略・SWOT・財務分析
    Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bumi Resources Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • 21st Century Oncology Inc:企業の戦略的SWOT分析
    21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • University of California Los Angeles:医療機器:M&Aディール及び事業提携情報
    Summary University of California Los Angeles (UCLA) a subsidiary of University of California, is an educational service provider that offers undergraduate education, graduate, professional education and continuing education. The university’s services include support services, campus services, gradua …
  • Ridley Corporation Ltd:企業の戦略・SWOT・財務分析
    Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Acorda Therapeutics Inc (ACOR):企業の財務・戦略的SWOT分析
    Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Good Energy Group PLC (GOOD)-エネルギー分野:企業M&A・提携分析
    Summary Good Energy Group PLC (Good Energy) is a vertically integrated utility, with operations in electricity and natural gas distribution businesses. It sources entire electricity from renewable sources including its own renewable generation assets, other renewable power producers and directly fro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆